The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Chathuri Yatawara,1 Fatin Zahra Zailan,1 Esther Vanessa Chua,1 Linda Lay Hoon Lim,1 Eveline Silva,1 Joanna Sihan Wang,1 Adeline Ng,1 Kok Pin Ng,1 Nagaendran Kandiah1– 3 1Department of Neurology, National Neuroscience Institute, Singapore, Singapore; 2Duke-NUS Medical School, Singapore, Sin...

Full description

Bibliographic Details
Main Authors: Yatawara C, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, Kandiah N
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Clinical Interventions in Aging
Subjects:
rivastigmine
alzheimer’s disease
small vessel cerebrovascular disease
treatment
Online Access:https://www.dovepress.com/the-efficacy-of-transdermal-rivastigmine-in-mild-to-moderate-alzheimer-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/the-efficacy-of-transdermal-rivastigmine-in-mild-to-moderate-alzheimer-peer-reviewed-article-CIA

Similar Items